STAT3 Dominant Negative Disease: NIH Cohort

被引：0

作者：

Freeman, Alexandra ^{[1
]}

Urban, Amanda ^{[2
]}

Martin, Iris ^{[3
]}

An, Zixiao ^{[4
]}

Ali, Sania ^{[5
]}

Lerman, Jacob ^{[6
]}

Lafeer, Christine ^{[7
]}

Roy, Susan ^{[8
]}

Ulrick, Jean ^{[7
]}

Davis, Joie ^{[3
]}

Bergerson, Jenna ^{[7
]}

Holland, Steven ^{[9
]}

Heimall, Jennifer ^{[10
]}

机构：

[1] NIAID, Lab Clin Immunol & Microbiol, NIH, Bethesda, MD USA

[2] Frederick Natl Lab Canc Res, Clin Res Directorate, Frederick, MD USA

[3] NIAID, NIH, Bethesda, MD USA

[4] NIAID, LCIM, Bethesda, MD USA

[5] Hackensack Meridian Sch Med, Hackensack, NJ USA

[6] NIAID, Lab Clin Immunol & Microbiol, NIH, Bethesda, MD USA

[7] NIAID, LCIM, NIH, Bethesda, MD USA

[8] Ctr Clin, NIH, Bethesda, MD USA

[9] NIAID, NIH, Div Intramural Res, Bethesda, MD USA

[10] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

来源：

CLINICAL IMMUNOLOGY | 2024年 / 262卷

关键词：

Hyper IgE syndrome; STAT3; Natural history;

D O I：

10.1016/j.clim.2024.110025

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：3

共 50 条

[1] Early intervention in STAT3 dominant negative disease
An, Zixiao Annie
Williams, Kelli W.
Urban, Amanda
Ali, Sania
Roy, Susan
Lafeer, Christine
Heimall, Jennifer
Dimitriades, Victoria R.
Davis, Joie
Kong, Heidi H.
Cowen, Edward W.
Holland, Steven M.
Freeman, Alexandra F.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (12): : 3795 - +
[2] Infectious Clinical Phenotype of STAT3 Dominant-Negative Disease
Ali, Sania
Williamson, Hastings
Urban, Amanda
Lafeer, Christine
Roy, Susan
Ulrick, Jean
Heimall, Jennifer
Freeman, Alexandra
JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (SUPPL 1) : S101 - S102
[3] Impact of Early Intervention for STAT3 Dominant-Negative Disease
An, Zixiao
Urban, Amanda
Roy, Susan
Ali, Sania
Heimall, Jennifer
Dimitriades, Victoria
Williams, Kelli
Freeman, Alexandra
CLINICAL IMMUNOLOGY, 2023, 250 : 102 - 102
[4] STAT3 beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription
Caldenhoven, E
vanDijk, TB
Solari, R
Armstrong, J
Raaijmakers, JAM
Lammers, JWJ
Koenderman, L
deGroot, RP
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) : 13221 - 13227
[5] Prevalence of Increased Hepatic Stiffness and Fat Fraction in STAT3 Dominant Negative Disease
Freeman, Alexandra
Urban, Amanda
Rai, Anjali
Roy, Susan
An, Annie
Heller, Theo
Gharib, Ahmed
CLINICAL IMMUNOLOGY, 2023, 250 : 44 - 45
[6] STAT3 and MAPK in human lung cancer tissues and suppression of oncogenic growth by JAB and dominant negative STAT3
Seki, Y
Suzuki, N
Imaizumi, M
Iwamoto, T
Usami, N
Ueda, Y
Hamaguchi, M
INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24 (04) : 931 - 934
[7] NK Cell Deficiency In Job Syndrome Patients With Dominant Negative STAT3 Mutations
Phatarpekar, Prasad V.
Mace, Emily M.
Orange, Jordan S.
Freeman, Alexandra F.
Holland, Steven M.
Lee, Dean A.
BLOOD, 2013, 122 (21)
[8] Reduced mTORC1 signal in patients with dominant negative STAT3 mutations
Edinger, Jacob
Zhang, Yuan
Youssef, Mariam
Blackstone, Sarah
Sun Guangping
Freeman, Alexandra
Milner, Joshua
JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (SUPPL 1) : S8 - S8
[9] Overexpression of a dominant negative form of STAT3 selectively impairs hematopoietic stem cell activity
Oh, IH
Eaves, CJ
ONCOGENE, 2002, 21 (31) : 4778 - 4787
[10] Dominant negative STAT3 suppresses the growth and invasion capability of human lung cancer cells
Xu, Guotai
Zhang, Cai
Zhang, Jian
MOLECULAR MEDICINE REPORTS, 2009, 2 (05) : 819 - 824

← 1 2 3 4 5 →